ArticleScientific reports2026
Comparative analysis of microRNA expression in serum-derived extracellular vesicles from sudden infant death syndrome cases.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Sudden infant death syndrome (SIDS) remains one of the most common and poorly understood diagnoses of death in infants. In this study, we searched for novel biomarkers to aid in elucidating the pathogenesis of SIDS through a bioinformatics analysis of serum-derived extracellular vesicle (EV) miRNAs using next-generation sequencing. Comparative analyses between infants who died of SIDS and those who died from known causes showed that 15 and 38 miRNAs were significantly up- or down-regulated more than twofold in SIDS, respectively. Myocardial-specific miRNAs, such as miR-1, miR-208, and miR-499, which are known to leak from injured heart, were up-regulated markedly in SIDS EVs. Gene target prediction analyses suggested that the MAP signaling pathway, cardiomyocytes, and cardiac ion channels are involved in the pathogenesis of SIDS. Gene ontology analyses revealed that protein phosphorylation, the actin cytoskeleton and myosin complex, and kinase activity are heavily involved in SIDS. Our results indicate that EV myocardial-specific miRNAs are released into the blood from the heart in SIDS, suggesting the pathogenesis of SIDS is associated with cardiac injury. Studies of EV miRNAs using minimally invasive fluid samples could lead to the discovery of new diagnostic markers for SIDS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.